You are here: Industry Insights > CDMO

News List

Symbiosis Secures $1.25M of Financing from Allied Irish Bank contractpharma
July 06, 2020
The fast growing Scottish CDMO will use the funds to support its 2020 growth strategy.
Emergent BioSolutions Enters Viral Vector and Gene Therapy Arena contractpharma
June 19, 2020
Invests $75mn in Canton site, advanced therapy CDMO drug substance manufacturing services expected to be available beginning in 2023.
Fujifilm commits $928m to expand biologics facility in Denmark pharmaceutical-technology
June 11, 2020
Fujifilm expects the capital investment to double the Denmark site's existing drug substance manufacturing capacity.
FUJIFILM Investing $928M in Denmark CDMO Site contractpharma
June 10, 2020
Will double the site's current drug substance manufacturing capacity and will expand capabilities to include fill/finish.
Alcami Names New CEO contractpharma
June 05, 2020
30-year pharma vet Walter J. Kaczmarek III takes the helm at the CDMO.
AGC Biologics Acquires AstraZeneca Facility contractpharma
June 05, 2020
Site located in Boulder, CO adds commercial-scale manufacturing capacity for its biopharmaceutical CDMO business.
Emergent to assist in production of US COVID-19 vaccine candidates europeanpharmaceuticalreview
June 03, 2020
The company announces it has been task ordered by BARDA to assist in the US government’s efforts to deliver COVID-19 vaccines.
WuXi AppTec Appoints Advanced Therapies CEO contractpharma
June 02, 2020
Dr. Chang will provide strategic, scientific and operational leadership to the company's global cell and gene therapy R&D and manufacturing services.
CDMO delivers 4000 doses of COVID-19 vaccine candidate for Phase II/III trial europeanpharmaceuticalreview
June 01, 2020
Advent announced it has manufactured and delivered the first 4000 doses of the AZD1222 vaccine candidate for the University of Oxford clinical trial.
CDMO pledges increased production of hydroxychloroquine sulfate, potential COVID-19 treatment europeanpharmaceuticalreview
May 08, 2020
The CDMO AMRI has said it will boost its production of the malaria drug hydroxychloroquine sulfate, identified as a potential COVID-19 treatment, following an emergency use authorisation from the FDA.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page